157 related articles for article (PubMed ID: 1747941)
1. Incidence of Harvey ras oncogene point mutations and their expression in methylbenzylnitrosamine-induced esophageal tumorigenesis.
Barch DH; Jacoby RF; Brasitus TA; Radosevich JA; Carney WP; Iannaccone PM
Carcinogenesis; 1991 Dec; 12(12):2373-7. PubMed ID: 1747941
[TBL] [Abstract][Full Text] [Related]
2. G-->A mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats.
Lozano JC; Nakazawa H; Cros MP; Cabral R; Yamasaki H
Mol Carcinog; 1994 Jan; 9(1):33-9. PubMed ID: 8297483
[TBL] [Abstract][Full Text] [Related]
3. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
[TBL] [Abstract][Full Text] [Related]
4. Incidence and effects of Ha-ras codon 12 G-->A transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine in the rat esophagus.
Liston BW; Gupta A; Nines R; Carlton PS; Kresty LA; Harris GK; Stoner GD
Mol Carcinog; 2001 Sep; 32(1):1-8. PubMed ID: 11568970
[TBL] [Abstract][Full Text] [Related]
5. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis.
Asamoto M; Toriyama-Baba H; Ohnishi T; Naito A; Ota T; Ando A; Ochiya T; Tsuda H
Jpn J Cancer Res; 2002 Jul; 93(7):744-51. PubMed ID: 12149139
[TBL] [Abstract][Full Text] [Related]
6. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Enomoto T; Ward JM; Perantoni AO
Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474
[TBL] [Abstract][Full Text] [Related]
7. Induction of esophageal tumors in zinc-deficient rats by single low doses of N-nitrosomethylbenzylamine (NMBA): analysis of cell proliferation, and mutations in H-ras and p53 genes.
Fong LY; Lau KM; Huebner K; Magee PN
Carcinogenesis; 1997 Aug; 18(8):1477-84. PubMed ID: 9276619
[TBL] [Abstract][Full Text] [Related]
8. Dietary zinc deficiency increases the methylbenzylnitrosamine-induced formation of O6-methylguanine in the esophageal DNA of the rat.
Barch DH; Fox CC
Carcinogenesis; 1987 Oct; 8(10):1461-4. PubMed ID: 3652382
[TBL] [Abstract][Full Text] [Related]
9. K-ras codon 12 and 61 point mutations in bromodeoxyuridine- and N-nitrosomethylurea-induced rat renal mesenchymal tumors.
Calvert RJ; Buzard GS; Anisimov VN; Rice JM
Cancer Lett; 1996 Dec; 109(1-2):1-7. PubMed ID: 9020896
[TBL] [Abstract][Full Text] [Related]
10. Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
Schmeiser HH; Janssen JW; Lyons J; Scherf HR; Pfau W; Buchmann A; Bartram CR; Wiessler M
Cancer Res; 1990 Sep; 50(17):5464-9. PubMed ID: 2201437
[TBL] [Abstract][Full Text] [Related]
11. Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.
Wang D; Weghorst CM; Calvert RJ; Stoner GD
Carcinogenesis; 1996 Apr; 17(4):625-30. PubMed ID: 8625469
[TBL] [Abstract][Full Text] [Related]
12. Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis.
Wang QS; Sabourin CL; Bijur GN; Robertson FM; Stoner GD
Mol Carcinog; 1996 Feb; 15(2):144-53. PubMed ID: 8599581
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of methylbenzylnitrosamine-induced formation of esophageal O6-methylguanine by dietary ellagic acid in rats.
Barch DH; Fox CC
Cancer Res; 1988 Dec; 48(24 Pt 1):7088-92. PubMed ID: 3191485
[TBL] [Abstract][Full Text] [Related]
14. Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.
Watatani M; Perantoni AO; Reed CD; Enomoto T; Wenk ML; Rice JM
Cancer Res; 1989 Mar; 49(5):1103-9. PubMed ID: 2645046
[TBL] [Abstract][Full Text] [Related]
15. High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline.
Takahashi M; Minamoto T; Sugimura T; Esumi H
Carcinogenesis; 1993 Jul; 14(7):1355-7. PubMed ID: 8330349
[TBL] [Abstract][Full Text] [Related]
16. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
17. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
[TBL] [Abstract][Full Text] [Related]
18. Activating point mutation in Ki-ras codon 63 in a chemically induced rat renal tumor.
Higinbotham KG; Rice JM; Perantoni AO
Mol Carcinog; 1992; 5(2):136-9. PubMed ID: 1554412
[TBL] [Abstract][Full Text] [Related]
19. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure.
Yuan B; Heniford BW; Ackermann DM; Hawkins BL; Hendler FJ
Cancer Res; 1994 Oct; 54(20):5310-7. PubMed ID: 7923158
[TBL] [Abstract][Full Text] [Related]
20. G --> A mutation of ras genes and infrequent p53 gene mutation in rat transplantable thyroid carcinoma lines from tumors induced in vivo by N-bis(2-hydroxypropyl)nitrosamine.
Kitahori Y; Naitoh H; Konishi N; Fukushima M; Ohnishi T; Hiasa Y
Cancer Lett; 1996 Feb; 100(1-2):55-62. PubMed ID: 8620454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
